Research Highlights on Atopic Dermatitis: Practice-Changing Results From Recent Clinical Trials *

; From the 2020 Annual Meetings of the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American Academy of Dermatology (AAD), and Revolutionizing Atopic Dermatitis (RAD).
Review the latest AD management data with Capsule Summaries and gain expert insights from brief commentaries and an on-demand Webcast covering key studies from the 2020 AAAAI, AAD, and RAD conferences.

Share

Program Content

6 Capsule Summary Slidesets

Activities

LIBERTY AD PEDS Results
LIBERTY AD PEDS Study Results: Efficacy and Safety of Dupilumab in Children Aged ≥ 6 to < 12 Yrs With Severe Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 20, 2020

Expires: July 19, 2021

JADE MONO-2 Results
JADE MONO-2 Study Results: Efficacy and Safety of Abrocitinib in Patients With Moderate to Severe Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 20, 2020

Expires: July 19, 2021

Upadacitinib Treatment Withdrawal and Retreatment
Efficacy and Safety of Treatment Withdrawal and Retreatment With Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2020

Expires: July 26, 2021

BREEZE-AD1/2 Pooled Data Results
Pooled Data From BREEZE-AD1 and BREEZE-AD2 Examining the Efficacy and Safety of Baricitinib in Patients With Atopic Dermatitis and Atopic Comorbidities
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2020

Expires: July 26, 2021

Dupilumab for Erythrodermic AD
Dupilumab for Erythrodermic AD: Results From a Pooled Subgroup Analysis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2020

Expires: July 26, 2021

BREEZE-AD5 Results
BREEZE-AD5 Study Results: Efficacy and Safety of Baricitinib in Patients With Moderate to Severe Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 11, 2020

Expires: August 10, 2021

Activities

New Data in AD
My Take on the Most Clinically Relevant New Data in Atopic Dermatitis
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2020

Expires: August 09, 2021

Selective JAK Inhibitors for AD
Selective JAK Inhibitors for Atopic Dermatitis: Important Additions to the Treatment Toolbox
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: August 12, 2020

Expires: August 11, 2021

Atopic Dermatitis Highlights
Research Highlights on Atopic Dermatitis: Practice-Changing Results from Recent Clinical Trials
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2020

Expires: September 20, 2021

Atopic Dermatitis Highlights
Research Highlights on Atopic Dermatitis: Practice-Changing Results From Recent Clinical Trials
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Andrew F. Alexis, MD, MPH

Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
Director, Skin of Color Center
Mount Sinai West and Mount Sinai Morningside
New York, New York

cover img faculity

Jonathan Silverberg, MD, PhD, MPH

Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine and Health Sciences
Washington, DC

Provided by

ProCE Banner

Supporters

This educational activity is supported by educational grants from

AbbVie Inc.

Pfizer, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.